Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
International Journal of Pharmaceutics
|
December 9, 2022
Formulation-dependent stability mechanisms affecting dissolution performance of directly compressed griseofulvin tablets
Natalie Maclean, Ibrahim Khadra, James Mann, et al.
International Journal of Pharmaceutics
|
April 4, 2021
Tablet disintegration performance: Effect of compression pressure and storage conditions on surface liquid absorption and swelling kinetics
Daniel Markl, Natalie Maclean, James Mann, et al.
International Journal of Pharmaceutics: X
|
January 3, 2022
Investigating the role of excipients on the physical stability of directly compressed tablets
Natalie Maclean, Ibrahim Khadra, James Mann, et al.
International Journal of Pharmaceutics: X
|
October 2, 2025
Making <i>in vitro</i> release and formulation data AI-ready: A foundation for streamlined nanomedicine development
Daniel Yanes, Heather Mead, James Mann, et al.
International Journal of Pharmaceutics
|
August 16, 2023
Developing a robust in vitro release method for a polymeric nanoparticle: Challenges and learnings
Heather Mead, Vasiliki Paraskevopoulou, Natalie Smith, et al.
Fungal Genetics and Biology : FG & B
|
February 7, 2020
Genomic characterization of Parengyodontium americanum sp. nov
Marcus de M Teixeira, Anna Muszewska, Jason Travis, et al.
Molecular Pharmaceutics
|
March 26, 2025
Correction to "Selecting Counterions to Improve Ionized Hydrophilic Drug Encapsulation in Polymeric Nanoparticles"
Savvas Dimiou, James McCabe, Rebecca Booth, et al.
Molecular Pharmaceutics
|
January 19, 2023
Selecting Counterions to Improve Ionized Hydrophilic Drug Encapsulation in Polymeric Nanoparticles
Savvas Dimiou, James McCabe, Rebecca Booth, et al.
Biorxiv : the Preprint Server for Biology
|
June 15, 2021
FXa cleaves the SARS-CoV-2 spike protein and blocks cell entry to protect against infection with inferior effects in B.1.1.7 variant
Wenjuan Dong, Jing Wang, Lei Tian, et al.
Pharmaceutics
|
May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series
Mark McAllister, Talia Flanagan, Susan Cole, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
International Journal of Pharmaceutics
|
December 9, 2022
Formulation-dependent stability mechanisms affecting dissolution performance of directly compressed griseofulvin tablets
Natalie Maclean, Ibrahim Khadra, James Mann, et al.
International Journal of Pharmaceutics
|
April 4, 2021
Tablet disintegration performance: Effect of compression pressure and storage conditions on surface liquid absorption and swelling kinetics
Daniel Markl, Natalie Maclean, James Mann, et al.
International Journal of Pharmaceutics: X
|
January 3, 2022
Investigating the role of excipients on the physical stability of directly compressed tablets
Natalie Maclean, Ibrahim Khadra, James Mann, et al.
International Journal of Pharmaceutics: X
|
October 2, 2025
Making <i>in vitro</i> release and formulation data AI-ready: A foundation for streamlined nanomedicine development
Daniel Yanes, Heather Mead, James Mann, et al.
International Journal of Pharmaceutics
|
August 16, 2023
Developing a robust in vitro release method for a polymeric nanoparticle: Challenges and learnings
Heather Mead, Vasiliki Paraskevopoulou, Natalie Smith, et al.
Fungal Genetics and Biology : FG & B
|
February 7, 2020
Genomic characterization of Parengyodontium americanum sp. nov
Marcus de M Teixeira, Anna Muszewska, Jason Travis, et al.
Molecular Pharmaceutics
|
March 26, 2025
Correction to "Selecting Counterions to Improve Ionized Hydrophilic Drug Encapsulation in Polymeric Nanoparticles"
Savvas Dimiou, James McCabe, Rebecca Booth, et al.
Molecular Pharmaceutics
|
January 19, 2023
Selecting Counterions to Improve Ionized Hydrophilic Drug Encapsulation in Polymeric Nanoparticles
Savvas Dimiou, James McCabe, Rebecca Booth, et al.
Biorxiv : the Preprint Server for Biology
|
June 15, 2021
FXa cleaves the SARS-CoV-2 spike protein and blocks cell entry to protect against infection with inferior effects in B.1.1.7 variant
Wenjuan Dong, Jing Wang, Lei Tian, et al.
Pharmaceutics
|
May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series
Mark McAllister, Talia Flanagan, Susan Cole, et al.
Page
of 2